Research and Markets: Global Lysosomal Storage Diseases Drug Pipeline Capsule - Keep a Track of Your Competitors and Understand Their Pipeline Molecules

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/e7e459/global_lysosomal_s) has announced the addition of the "Global Lysosomal Storage Diseases Drug Pipeline Capsule - 2011" report to their offering.

Fore Pharma's latest report Global Lysosomal Storage Diseases Drug Pipeline Capsule - 2011' is an outline of all the key research and development (R&D) activities of the global lysosomal storage diseases drug market. It covers information on key pipeline molecules in various stages of R&D including all the phases of clinical trials, preclinical research, and drug discovery. The report is up-to-date with full coverage of the licensing activities and partnerships.

The information presented in this report can be used by executives for identifying the partners, prioritizing, evaluating opportunities, developing business development strategies, and executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company and mechanism of action across the different stages of R&D. It includes registered / preregistered stage, phase 3 clinical trial, phase 2 clinical trial, phase 1 clinical trial, preclinical research, and drug discovery. It also provides information on pipeline molecules developed in leading geographies including the U.S., Canada, France, Germany, U.K., Italy, and Spain by various stages of R&D. Licensing activities and partnerships in the lysosomal storage diseases drug market is thoroughly covered by company and licensee with the deal summary.

The key topics covered by Global Lysosomal Storage Diseases Drug Pipeline Capsule - 2011 include:

  • Lysosomal Storage Diseases: Overview
  • Lysosomal Storage Diseases Drug Pipeline Overview
  • Lysosomal Storage Diseases Phase 3 Clinical Trial Drug Pipeline Insights
  • Lysosomal Storage Diseases Phase 2 Clinical Trial Drug Pipeline Insights
  • Lysosomal Storage Diseases Phase 1 Clinical Trial Drug Pipeline Insights
  • Lysosomal Storage Diseases Preclinical Research Drug Pipeline Insights
  • Lysosomal Storage Diseases Drug Discovery Pipeline Insights
  • Geographic Landscape of Lysosomal Storage Diseases R&D Activities
  • Lysosomal Storage Diseases R&D Activities in North America
  • Lysosomal Storage Diseases R&D Activities in Europe
  • Licensing Activities / Partnerships in the Global Lysosomal Storage Diseases Drug Market

For more information visit http://www.researchandmarkets.com/research/e7e459/global_lysosomal_s

Contacts

Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716